Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare M Isacke

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Cancer Research|November 3, 2007
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivoDirk Wienke, Gareth C Davies, Damian A Johnson, et al.
Cancer Research|October 6, 2023
Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast CancersArany Soosainathan, Marjan Iravani, Rania El-Botty, et al.
Genome Biology|October 25, 2011
High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencingDavid Sims, Ana M Mendes-Pereira, Jessica Frankum, et al.
Breast Cancer Research and Treatment|April 27, 2012
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorElizabeth Iorns, Toby M Ward, Sonja Dean, et al.
The Lancet. Oncology|February 1, 2024
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendationsIcro Meattini, Carlotta Becherini, Saverio Caini, et al.
Cancer Discovery|February 13, 2014
An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressorNirupa Murugaesu, Marjan Iravani, Antoinette van Weverwijk, et al.
Cell|June 20, 2020
Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived EicosanoidsNikos Koundouros, Evdoxia Karali, Aurelien Tripp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysisViola Salvestrini, Kyubo Kim, Saverio Caini, et al.
Oncogene|October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene|June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Cancer Research|November 3, 2007
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivoDirk Wienke, Gareth C Davies, Damian A Johnson, et al.
Cancer Research|October 6, 2023
Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast CancersArany Soosainathan, Marjan Iravani, Rania El-Botty, et al.
Genome Biology|October 25, 2011
High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencingDavid Sims, Ana M Mendes-Pereira, Jessica Frankum, et al.
Breast Cancer Research and Treatment|April 27, 2012
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorElizabeth Iorns, Toby M Ward, Sonja Dean, et al.
The Lancet. Oncology|February 1, 2024
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendationsIcro Meattini, Carlotta Becherini, Saverio Caini, et al.
Cancer Discovery|February 13, 2014
An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressorNirupa Murugaesu, Marjan Iravani, Antoinette van Weverwijk, et al.
Cell|June 20, 2020
Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived EicosanoidsNikos Koundouros, Evdoxia Karali, Aurelien Tripp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysisViola Salvestrini, Kyubo Kim, Saverio Caini, et al.
Oncogene|October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene|June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Pageof 10